
UnitedHealth Group (UNH) received a 77% rating from Validea's P/B Growth Investor model, based on Partha Mohanram's academically validated strategy for identifying outperforming low book-to-market growth stocks. As a large-cap health insurance firm, UNH demonstrated strong fundamentals, passing most criteria like return on assets and cash flow, though it failed on advertising and R&D to asset metrics, positioning it just below the model's 80% 'interest' threshold despite its overall robust profile for sustained growth.
UnitedHealth Group (UNH) scores a moderately positive 77% on Validea's P/B Growth Investor model, a framework developed by Partha Mohanram to identify high-potential growth stocks among low book-to-market companies. As a large-cap stock in the health insurance industry, UNH demonstrates robust underlying fundamentals, passing critical tests for Return on Assets, Cash Flow from Operations to Assets, and stability metrics such as variance in both ROA and sales. This profile suggests strong operational efficiency and financial health. However, the score is held just below the model's 80% 'interest' threshold due to failures in two specific criteria: Advertising to Assets and Research and Development to Assets. While the company exhibits many characteristics associated with sustained future growth, its investment profile in these two areas does not align with the specific metrics this particular academic model uses to separate top-tier growth stocks from their peers.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment